# Johns Hopkins All Children's Hospital – FDA Inspection, Feb 13, 2020

Source: https://www.keypedia.com/records/fda_inspections/johns-hopkins-all-childrens-hospital/192f07c6-71f6-455e-acc4-0eda26572799
Source feed: FDA_Inspections

> FDA inspection 1121333 of Johns Hopkins All Children's Hospital, February 13, 2020. Classification: No Action Indicated (NAI). 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1121333
- Company Name: Johns Hopkins All Children's Hospital
- Inspection Date: 2020-02-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1273922 - 2025-06-12](https://www.keypedia.com/records/fda_inspections/johns-hopkins-all-childrens-hospital/5c923672-2270-4ebd-99a4-c6aecd61f7db)
- FDA Inspection 1029090 - 2017-08-16
- FDA Inspection 939646 - 2015-08-20
- FDA Inspection 854708 - 2013-11-07
- FDA Inspection 763475 - 2012-01-19

Company: https://www.keypedia.com/companies/johns-hopkins-all-childrens-hospital/dfdad0d9-0b9b-4074-9beb-416dc811bc89

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d
